0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
ARTICLE |

Treatment of Poorly Regulated Non-Insulin-Dependent Diabetes Mellitus With Combination Insulin-Sulfonylurea

B. Titus Allen, MD; Mark N. Feinglos, MD; Harold E. Lebovitz, MD
Arch Intern Med. 1985;145(10):1900-1903. doi:10.1001/archinte.1985.00360100170028.
Text Size: A A A
Published online

Non–insulin-dependent diabetes mellitus (NIDDM) is characterized by increased hepatic glucose production and deficient peripheral glucose uptake.1 These disturbances in glucose metabolism are thought to result from cellular resistance to insulin action and deficient secretion of insulin.2,3

The cellular resistance to insulin action is caused by disturbances in one or more postreceptor sites of insulin action.4,5 Decrease in insulin binding does occur, but it is thought to be due to down-regulation of the insulin receptor secondary to the increased basal plasma insulin levels.5 A small direct decrease in insulin receptors in NIDDM cannot be excluded as a contributory cause to the insulin resistance.

The β cell in patients with NIDDM does not secrete insulin appropriately in response to glucose.3 This abnormality is likely the result of an intracellular disturbance and results in delayed as well as insufficient glucose-mediated insulin secretion.6 As the level of fasting hyperglycemia increases, β-cell glucose-mediated insulin

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Correspondence

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Web of Science® Times Cited: 29

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();